403 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
JAZZ Jazz Pharmaceuticals plc $161.01 $9.73B Downtrend
Article Searches
Jazz Pharma (JAZZ) Q4 Earnings & Sales Beat, Stock Up 8% http://www.zacks.com/stock/news/357054/jazz-pharma-jazz-q4-earnings-sales-beat-stock-up-8?cid=CS-ZC-FT-357054 Feb 27, 2019 - Jazz Pharmaceuticals (JAZZ) surpasses earnings and sales estimates in the fourth quarter and issues a solid outlook for 2019. Shares rise 8% in after-hours trading.
Jazz Pharmaceuticals PLC (JAZZ) Q4 2018 Earnings Conference Call Transcript https://www.fool.com/earnings/call-transcripts/2019/02/27/jazz-pharmaceuticals-plc-jazz-q4-2018-earnings-con.aspx?source=iedfolrf0000001 Feb 27, 2019 - JAZZ earnings call for the period ending December 31, 2018.
Jazz Pharmaceuticals, Inc. (JAZZ) CEO Bruce Cozadd on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4244549-jazz-pharmaceuticals-inc-jazz-ceo-bruce-cozadd-q4-2018-results-earnings-call-transcript?source=feed_sector_healthcare Feb 26, 2019 - Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) Q4 2018 Earnings Conference Call February 26, 2019, 04:30 PM ET Company Participants Katherine Littrell - Head of IR Bruce Cozadd - Chairman and Chief Executiv
Jazz Pharmaceuticals, Inc. 2018 Q4 - Results - Earnings Call Slides https://seekingalpha.com/article/4244496-jazz-pharmaceuticals-inc-2018-q4-results-earnings-call-slides?source=feed_sector_healthcare Feb 26, 2019 - The following slide deck was published by Jazz Pharmaceuticals, Inc. in conjunction with their 2018 Q4 earnings call.
After-Hours Report: TNDM +18.2%, JAZZ +9.6%, IMMR -11.6%, WLL -10.9%, ELF -10.1% on earnings/guidance: http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=NS20190226170830AfterHoursReport Feb 26, 2019 - The S&P 500 decreased 0.1% as it struggled for direction on Tuesday. The stock market wavered betwee
Ken Nordine, Surreal Poet With a Jazz Beat, Is Dead at 98 https://www.nytimes.com/2019/02/22/obituaries/ken-nordine-dead.html?partner=rss&emc=rss Feb 22, 2019 - His improvisational poetry, which he called “word jazz,” attracted admiring collaborators like Fred Astaire, Jerry Garcia, Tom Waits and Laurie Anderson.
Kiyoshi Koyama, Prominent Japanese Jazz Journalist, Dies at 82 https://www.nytimes.com/2019/02/17/obituaries/kiyoshi-koyama-dead.html?partner=rss&emc=rss Feb 20, 2019 - As the editor of his country’s leading jazz magazine, he documented the music’s development. As a producer of archival albums, he helped document its past.
Fans of Max Roach drumming up support to rename Bed-Stuy street after genre-busting jazz great http://www.nydailynews.com/new-york/ny-metro-max-roach-street-renaming-20190219-story.html Feb 19, 2019 -

The fan-fueled beat is growing louder for the renaming of a Bedford-Stuyvesant street to honor legendary jazz drummer Max Roach.

Nearly 3,000 supporters of the adventurous bebop percussionist already signed a change.org petition in support of the tribute for native son Roach, who spent his childhood...

Grammys 2019: Jazz trumpeter John Daversa lifts up Dreamers with his Grammy wins http://www.latimes.com/entertainment/music/la-et-ms-grammys-american-dreamers-daversa-daca-20190210-story.html Feb 10, 2019 -

When trumpeter John Daversa swept his categories by winning three awards for work from his big-band album “American Dreamers (Voices of Hope, Music of Freedom),” at the top of his thank-you list were 53 musicians on the album. All of them were legally living in the United States as so-called Dreamers...

Why Jazz (JAZZ) Could Beat Earnings Estimates Again http://www.zacks.com/stock/news/352518/why-jazz-jazz-could-beat-earnings-estimates-again?cid=CS-ZC-FT-352518 Feb 06, 2019 - Jazz (JAZZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Pages: 1234567891011...41

<<<Page 6>